LAUSR

About 55 years ago, I read Ernest Hemingway's A Farewell to Arms for a second time. I read it for the first time during my college years when I was considering going to medical school. Also about 55 years ago, I was starting to more carefully read journal articles describing clinical trials (it is nowokay to split infinitives). Many years later, I remember being amused when I first came across the term treatment arms. Words with multiple meanings (homonyms) have always fascinated me (eg, run, break). Arm is actually a word with 3 meanings (ie, weapon [noun and verb = to arm], limb, cohort). Fast forward to the late 1970s when I had already been teaching psychopharmacology for about 10 years—often using my own text,Manual of Psychiatric Therapeutics, which was initially in a convenient spiral-bound format. It occurred to me that there was an unmet need in our field for a peer-reviewed journal dedicated to clinical psychopharmacology. Remember, people were still reading and learning from print materials at that time. I approached my textbook publisher, Williams &Wilkins, and in 1981, we launched the first volume of the Journal of Clinical Psychopharmacology (JCP). I also made an unquestionably wise decision to ask my friend and research colleague, David J. Greenblatt, to join me as Co–Editor-in-Chief. Looking back at the first issue of the first volume, we published an article titled “Lithium and marijuana”—I never would have guessed then that marijuana use would become so pervasive. We also carried advertising in our early years. Our first major and primary advertiser was the Mead Johnson Pharmaceutical Division (MJPD). They also provided free subscriptions to JCP to first-year psychiatric residents for our first 5 years. The MJPD was acquired by Bristol-Myers in 1967. Bristol-Myers merged with the Squibb Corporation in 1989. TheMJPD became separate again in 2009 and was renamedMead Johnson Nutrition Company; they no longer have connections with psychopharmacology. In 2017,